Company attributes
Industry
Location
B2X
CEO
Founder
AngelList URL
Number of Employees (Ranges)
11 – 50
Email Address
contact@domaintherapeutics.com0
contactdtna@domaintherapeutics.com0
Full Address
adMare Institute - 7171 Frédérick Banting H4S 1Z9 Montreal - Canada0
Bioparc 1 - 850 Boulevard Sébastien Brant 67400 Strasbourg - Illkirch - France0
Investors
Founded Date
2001
Total Funding Amount (USD)
98,556,200
Latest Funding Round Date
May 10, 2022
Board of Directors
Latest Funding Type
Patents Assigned (Count)
1
Wellfound ID
Other attributes
Company Operating Status
Active
Invested in
Latest Funding Round Amount (USD)
42,000,000
Wikidata ID
DOMAIN Therapeutics is a company that is committed to improving patients’ life by delivering innovative cancer immunotherapies and treatments for neurologic disorders and rare diseases.
The company aims to make an impactful difference for patients who suffer from cancer by discovering treatments that address GPCR -mediated immunosuppression.
The company develops a robust pipeline in immune-oncology and progresses its advanced programs towards the clinic, using its expertise, innovative approach and proprietary platform.
The company has also built a pipeline of GPCR-based programs in neurology and rare diseases over the past decade. Domain is developing by establishing early partnerships on its neurology and rare disease assets..
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
